Specialist vendors taking larger share of EMR market

Laura Pedulli | | Health Exec | EMR/EHR

The $23 billion EMR market once was dominated by large health IT firms, but specialized EMRs are gaining ground, according to a report from Kalorama Information.

Overall, the market is fragmented, with 52 percent of the market held by smaller and mid-size specialized companies, which is up from 42 percent last year. While these companies all gained some market share, McKesson, GE Healthcare and Siemens all lost ground in the market.

Epic, which specializes in EMRs, moved from fourth to third place in its market share estimates.

"Epic is making inroads into the market and will undoubtedly provide sustained competition for Cerner in this area. McKesson, although strong in the industry as a whole, seems to be losing hospital market share to some of the other companies more targeted in EMR," said Mary Ann Crandall, Kalorama analyst, in a statement.

The EMR market has no clear forerunner, and thus there is ample opportunity for entrants, especially with online services. Also, there appears to be room for additional mergers and acquisitions, according to Kalorama.

Laura Pedulli

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.